All
The wrong financial adviser could cost you millions
September 1st 2011The single most common mistake we see in our physician-focused practice is in the doctors’ choice of specialists. The successful delivery of healthcare is based on the patients’ need for physicians to refer them within and between various specialties and subspecialties when unique challenges arise. When it comes to the successful navigation of their own financial health, however, physicians do not apply the same logic or expect the same level of sophistication from their advisers.
Lesion-directed topical therapy safe for actinic keratosis
September 1st 2011A new topical therapy combining low-dose 5-fluorouracil (5-FU) with salicylic acid is proving very effective in the treatment of actinic keratosis (AK), particularly in more difficult to treat advanced hyperkeratotic AK lesions, study results show.
Dermatologists struggle with electronic health record implementation
September 1st 2011While the implementation of health information technology (HIT) systems in medical practices has the potential of improving healthcare efficiency and patient care, there are obstacles that medical practices must overcome, and those problems are especially acute for small practices such as those operated by many dermatologists.
Afamelanotide for vitiligo to be tested in international clinical trial
September 1st 2011The addition of afamelanotide, known by the trademark Scenesse (Clinuvel), may represent a major advance in the treatment of vitiligo, a condition for which there is no therapy in the United States that has been approved by the Food and Drug Administration.
Potential cuts to medical programs leaves dermatologists uncertain about future
September 1st 2011When the United States reached a virtual gridlock in July over raising the country's debt ceiling, most politicians agreed that the country needed to cut spending to bring the nation's budget back into line. With the medical component of the proposed spending cuts, On Call wondered how dermatologists viewed the political gymnastics occurring in Washington and how the impact on Medicare and Medicaid would affect their practices and medicine in the future.
Alopecia areata responds to skin-directed therapy
September 1st 2011Although large, randomized, controlled trials of topical treatments for alopecia areata (AA) are lacking, experts say many such treatments provide varying degrees of success. When it comes to AA, says Jerry Shapiro, M.D., "Some dermatologists still believe nothing works." He is adjunct professor, department of dermatology, New York University, New York.
Segmental pigmentation not associated with systemic manifestations, study finds
September 1st 2011Although patterned pigmentation in children can include a variety of clinical findings involving neurologic, musculoskeletal and cardiac abnormalities, most localized pigmentary disorders are not associated with systemic manifestations, according to pediatric dermatologist James Treat, M.D., University of Pennsylvania School of Medicine, Philadelphia.
Electrolysis successful where laser hair removal fails
September 1st 2011Electrolysis provides a safe, permanent alternative for patients who don't want or are not appropriate for laser treatments. Electrolysis, which uses current passed through a needle inserted down the hair follicle, is the only method approved by the Food and Drug Administration (FDA) for permanent hair removal.
Concept of medical necessity can support services when being audited
September 1st 2011With the mandatory integration of electronic medical records (EMR) into the physician's practice, it would seem that future RAC or carrier audits will be seamlessly easy to navigate and win. As more and more dermatologists start using this electronic documentation tool in their offices, however, I am being bombarded by questions and concerns from the new users - both physicians who are clients and those who are not.
Careful evaluation, therapies resolve pigmented lesions
September 1st 2011Treatment of pigmented lesions has evolved over the past five to 10 years, according to Eliot Battle Jr., M.D., cosmetic dermatologist and chief executive officer, Cultura Dermatology & Laser Center, Washington, and clinical instructor, department of dermatology, Howard University Hospital.
Pediatric literature gives insight on new therapies for children
September 1st 2011Recent publications in pediatric literature are driving practice changes relative to conditions ranging from Kawasaki disease to child abuse to hemangiomas. Perhaps the most important recent pediatric publication many dermatologists may have missed addresses evaluating abuse versus accidental trauma in infants and young children, says Robert Sidbury, M.D., M.P.H., chief of pediatric dermatology and associate professor of pediatrics, Seattle Children's Hospital.
Physicians must ensure hearing-impaired patients understand their options
September 1st 2011Mr. Eye, who was hearing impaired, was to be scheduled for Mohs micrographic surgery. Unfortunately, before his surgery he became ill and did not recover, nor did he return to Dr. Skin's office for six months. Unfortunately, Dr. Skin's staff had forgotten about Mr. Eye's hearing impairment. They took his lack of response as senility consistent with his age. Dr. Skin chose to use only palliative treatment while watching the carcinoma invade Mr. Eye's orbit over the next year.
Molecular diagnostic strategies redefine therapies for various skin disorders
September 1st 2011Molecular diagnostic strategies are redefining the clinical management of a wide range of skin disorders, facilitating diagnosis, staging and prognostication, selection of appropriate therapy, monitoring of treatment response and identification of novel therapeutic targets.
Evaluating suspicious lesions requires equipment, expertise
September 1st 2011When analyzing suspicious lesions, any diagnostic tool is only as good as the physician using it. Besides patients' suspicions, dermatologists can rely on objective diagnostic tools including dermoscopy and total body photography.
Vulvar disease, related disorders needn't intimidate dermatologists
September 1st 2011Although treating patients with vulvar disorders can be challenging, confidence and compassion go a long way toward helping these patients. Sometimes, dermatologists allow themselves to be intimidated by the idea that vulvar and mucosal problems differ vastly from the usual issues they treat.
Hyaluronic acid fillers feature key differences, but perform similarly
September 1st 2011Many physicians don't understand the key characteristics that differentiate currently available hyaluronic acid (HA) dermal fillers, says Derek H. Jones, M.D., clinical associate professor of dermatology, University of California, Los Angeles.